Skip to main content
Erschienen in: Journal of Cardiovascular Translational Research 5/2020

01.10.2020 | Original Article

Outcomes of Direct Flow Medical vs Sapien 3 Transcatheter Aortic Valve Devices

verfasst von: Amr S. Gamal, Subhi Akleh, Azfar Zaman, Rajiv Das, Abdelrahman Ibrahim Abushouk, Richard Edwards

Erschienen in: Journal of Cardiovascular Translational Research | Ausgabe 5/2020

Einloggen, um Zugang zu erhalten

Abstract

This retrospective study was aimed to compare the safety and efficacy of the Direct Flow Medical (DFM) valve with the more established Sapien 3 (S3) valve in transfemoral TAVI in high-risk aortic stenosis (AS) patients. Between February 2014 and August 2016, 99 and 68 patients had the S3 and DFM valves at our center, respectively. The device success rate was statistically similar among the S3 and DFM groups (p = 0.15). The overall post-procedural complication rate was similar between the two groups (p = 0.4). The procedural time was significantly shorter in the S3 group (p < 0.001) and the post-procedure peak pressure gradient (p < 0.001) was significantly higher in the DFM group. However, the frequency of valvular or paravalvular leaks was similar between both valve groups. We found no significant differences in terms of safety between the DFM and S3 valves. This study confirms the safety and efficacy of the DFM valve in high-risk AS patients.
Literatur
1.
Zurück zum Zitat Webb, J., & Cribier, A. (2010). Percutaneous transarterial aortic valve implantation: what do we know? European Heart Journal, 32(2), 140–147.CrossRef Webb, J., & Cribier, A. (2010). Percutaneous transarterial aortic valve implantation: what do we know? European Heart Journal, 32(2), 140–147.CrossRef
2.
Zurück zum Zitat Piazza, N., et al. (2008). Procedural and 30-day outcomes following transcatheter aortic valve implantation using the third generation (18 Fr) corevalve revalving system: results from the multicentre, expanded evaluation registry 1-year following CE mark approval. EuroIntervention: Journal OF EuroPCR in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, 4(2), 242–249.CrossRef Piazza, N., et al. (2008). Procedural and 30-day outcomes following transcatheter aortic valve implantation using the third generation (18 Fr) corevalve revalving system: results from the multicentre, expanded evaluation registry 1-year following CE mark approval. EuroIntervention: Journal OF EuroPCR in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, 4(2), 242–249.CrossRef
3.
Zurück zum Zitat Grube, E., et al. (2007). Percutaneous aortic valve replacement for severe aortic stenosis in high-risk patients using the second-and current third-generation self-expanding CoreValve prosthesis: device success and 30-day clinical outcome. Journal of the American College of Cardiology, 50(1), 69–76.CrossRef Grube, E., et al. (2007). Percutaneous aortic valve replacement for severe aortic stenosis in high-risk patients using the second-and current third-generation self-expanding CoreValve prosthesis: device success and 30-day clinical outcome. Journal of the American College of Cardiology, 50(1), 69–76.CrossRef
4.
Zurück zum Zitat Cribier, A., et al. (2006). Treatment of calcific aortic stenosis with the percutaneous heart valve: mid-term follow-up from the initial feasibility studies: the French experience. Journal of the American College of Cardiology, 47(6), 1214–1223.CrossRef Cribier, A., et al. (2006). Treatment of calcific aortic stenosis with the percutaneous heart valve: mid-term follow-up from the initial feasibility studies: the French experience. Journal of the American College of Cardiology, 47(6), 1214–1223.CrossRef
5.
Zurück zum Zitat Cribier, A., et al. (2004). Early experience with percutaneous transcatheter implantation of heart valve prosthesis for the treatment of end-stage inoperable patients with calcific aortic stenosis. Journal of the American College of Cardiology, 43(4), 698–703.CrossRef Cribier, A., et al. (2004). Early experience with percutaneous transcatheter implantation of heart valve prosthesis for the treatment of end-stage inoperable patients with calcific aortic stenosis. Journal of the American College of Cardiology, 43(4), 698–703.CrossRef
6.
Zurück zum Zitat Leon, M. B., et al. (2010). Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. New England Journal of Medicine, 363(17), 1597–1607.CrossRef Leon, M. B., et al. (2010). Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. New England Journal of Medicine, 363(17), 1597–1607.CrossRef
7.
Zurück zum Zitat Smith, C. R., et al. (2011). Transcatheter versus surgical aortic-valve replacement in high-risk patients. New England Journal of Medicine, 364(23), 2187–2198.CrossRef Smith, C. R., et al. (2011). Transcatheter versus surgical aortic-valve replacement in high-risk patients. New England Journal of Medicine, 364(23), 2187–2198.CrossRef
8.
Zurück zum Zitat Elmaraezy, A., et al. (2017). Efficacy and safety of transcatheter aortic valve replacement in aortic stenosis patients at low to moderate surgical risk: a comprehensive meta-analysis. BMC Cardiovascular Disorders, 17(1), 234.CrossRef Elmaraezy, A., et al. (2017). Efficacy and safety of transcatheter aortic valve replacement in aortic stenosis patients at low to moderate surgical risk: a comprehensive meta-analysis. BMC Cardiovascular Disorders, 17(1), 234.CrossRef
9.
Zurück zum Zitat Czerwińska-Jelonkiewicz, K., et al. (2014). Vascular complications after transcatheter aortic valve implantation (TAVI): risk and long-term results. Journal of Thrombosis and Thrombolysis, 37(4), 490–498.CrossRef Czerwińska-Jelonkiewicz, K., et al. (2014). Vascular complications after transcatheter aortic valve implantation (TAVI): risk and long-term results. Journal of Thrombosis and Thrombolysis, 37(4), 490–498.CrossRef
10.
Zurück zum Zitat Mussardo, M., et al. (2011). Periprocedural and short-term outcomes of transfemoral transcatheter aortic valve implantation with the Sapien XT as compared with the Edwards Sapien valve. JACC: Cardiovascular Interventions, 4(7), 743–750.PubMed Mussardo, M., et al. (2011). Periprocedural and short-term outcomes of transfemoral transcatheter aortic valve implantation with the Sapien XT as compared with the Edwards Sapien valve. JACC: Cardiovascular Interventions, 4(7), 743–750.PubMed
11.
Zurück zum Zitat Buellesfeld, L., et al. (2011). 2-year follow-up of patients undergoing transcatheter aortic valve implantation using a self-expanding valve prosthesis. Journal of the American College of Cardiology, 57(16), 1650–1657.CrossRef Buellesfeld, L., et al. (2011). 2-year follow-up of patients undergoing transcatheter aortic valve implantation using a self-expanding valve prosthesis. Journal of the American College of Cardiology, 57(16), 1650–1657.CrossRef
12.
Zurück zum Zitat Thomas, M., et al. (2010). Thirty-day results of the SAPIEN aortic Bioprosthesis European Outcome (SOURCE) Registry: a European registry of transcatheter aortic valve implantation using the Edwards SAPIEN valve. Circulation, 122(1), 62–69.CrossRef Thomas, M., et al. (2010). Thirty-day results of the SAPIEN aortic Bioprosthesis European Outcome (SOURCE) Registry: a European registry of transcatheter aortic valve implantation using the Edwards SAPIEN valve. Circulation, 122(1), 62–69.CrossRef
13.
Zurück zum Zitat Rodés-Cabau, J., et al. (2010). Transcatheter aortic valve implantation for the treatment of severe symptomatic aortic stenosis in patients at very high or prohibitive surgical risk: acute and late outcomes of the multicenter Canadian experience. Journal of the American College of Cardiology, 55(11), 1080–1090.CrossRef Rodés-Cabau, J., et al. (2010). Transcatheter aortic valve implantation for the treatment of severe symptomatic aortic stenosis in patients at very high or prohibitive surgical risk: acute and late outcomes of the multicenter Canadian experience. Journal of the American College of Cardiology, 55(11), 1080–1090.CrossRef
14.
Zurück zum Zitat Lefèvre, T., et al. (2016). Prospective multicenter evaluation of the direct flow medical transcatheter aortic valve system: 12-month outcomes of the evaluation of the direct flow medical percutaneous aortic valve 18F system for the treatment of patients with severe aortic stenosis (DISCOVER) study. JACC: Cardiovascular Interventions, 9(1), 68–75.PubMed Lefèvre, T., et al. (2016). Prospective multicenter evaluation of the direct flow medical transcatheter aortic valve system: 12-month outcomes of the evaluation of the direct flow medical percutaneous aortic valve 18F system for the treatment of patients with severe aortic stenosis (DISCOVER) study. JACC: Cardiovascular Interventions, 9(1), 68–75.PubMed
15.
Zurück zum Zitat De Marco, F., & Latib, A. (2014). Tools and techniques–clinical: The inner curve technique for implantation of the Direct Flow Medical® transcatheter aortic valve. EuroIntervention, 10(3), 400–402.CrossRef De Marco, F., & Latib, A. (2014). Tools and techniques–clinical: The inner curve technique for implantation of the Direct Flow Medical® transcatheter aortic valve. EuroIntervention, 10(3), 400–402.CrossRef
16.
Zurück zum Zitat Zhang, Y., et al. (2015). Propensity-matched comparison between Direct Flow Medical, Medtronic Corevalve, and Edwards Sapien XT prostheses: Device success, thirty-day safety, and mortality. Catheterization and Cardiovascular Interventions, 85(7), 1217–1225.CrossRef Zhang, Y., et al. (2015). Propensity-matched comparison between Direct Flow Medical, Medtronic Corevalve, and Edwards Sapien XT prostheses: Device success, thirty-day safety, and mortality. Catheterization and Cardiovascular Interventions, 85(7), 1217–1225.CrossRef
17.
Zurück zum Zitat Giustino, G., et al. (2015). Early outcomes with direct flow medical versus first-generation transcatheter aortic valve devices: a single-center propensity-matched analysis. Journal of Interventional Cardiology, 28(6), 583–593.CrossRef Giustino, G., et al. (2015). Early outcomes with direct flow medical versus first-generation transcatheter aortic valve devices: a single-center propensity-matched analysis. Journal of Interventional Cardiology, 28(6), 583–593.CrossRef
18.
Zurück zum Zitat Baumgartner, H., et al. (2017). 2017 ESC/EACTS guidelines for the management of valvular heart disease. European Heart Journal, 38(36), 2739–2791.CrossRef Baumgartner, H., et al. (2017). 2017 ESC/EACTS guidelines for the management of valvular heart disease. European Heart Journal, 38(36), 2739–2791.CrossRef
19.
Zurück zum Zitat Lang, R. M., et al. (2006). Recommendations for chamber quantification. European Journal of Echocardiography, 7(2), 79–108.CrossRef Lang, R. M., et al. (2006). Recommendations for chamber quantification. European Journal of Echocardiography, 7(2), 79–108.CrossRef
20.
Zurück zum Zitat Kappetein, A. P., et al. (2013). Updated standardized endpoint definitions for transcatheter aortic valve implantation: The Valve Academic Research Consortium-2 consensus document∗. The Journal of Thoracic and Cardiovascular Surgery, 145(1), 6–23.CrossRef Kappetein, A. P., et al. (2013). Updated standardized endpoint definitions for transcatheter aortic valve implantation: The Valve Academic Research Consortium-2 consensus document∗. The Journal of Thoracic and Cardiovascular Surgery, 145(1), 6–23.CrossRef
21.
Zurück zum Zitat Ye, S. Q., et al. (2005). Pre–B-cell colony-enhancing factor as a potential novel biomarker in acute lung injury. American Journal of Respiratory and Critical Care Medicine, 171(4), 361–370.CrossRef Ye, S. Q., et al. (2005). Pre–B-cell colony-enhancing factor as a potential novel biomarker in acute lung injury. American Journal of Respiratory and Critical Care Medicine, 171(4), 361–370.CrossRef
22.
Zurück zum Zitat Webb, J. G., et al. (2007). Percutaneous transarterial aortic valve replacement in selected high-risk patients with aortic stenosis. Circulation, 116(7), 755–763.CrossRef Webb, J. G., et al. (2007). Percutaneous transarterial aortic valve replacement in selected high-risk patients with aortic stenosis. Circulation, 116(7), 755–763.CrossRef
23.
Zurück zum Zitat Geisbüsch, S., et al., Incidence and management of CoreValve dislocation during transcatheter aortic valve implantation. Circulation: Cardiovascular Interventions, 2010: p. CIRCINTERVENTIONS. 110.944983. Geisbüsch, S., et al., Incidence and management of CoreValve dislocation during transcatheter aortic valve implantation. Circulation: Cardiovascular Interventions, 2010: p. CIRCINTERVENTIONS. 110.944983.
24.
Zurück zum Zitat Schulz, E., et al. (2017). Comparison of transcatheter aortic valve implantation with the newest-generation Sapien 3 vs. Direct Flow Medical valve in a single center cohort. International Journal of Cardiology, 232, 186–191.CrossRef Schulz, E., et al. (2017). Comparison of transcatheter aortic valve implantation with the newest-generation Sapien 3 vs. Direct Flow Medical valve in a single center cohort. International Journal of Cardiology, 232, 186–191.CrossRef
25.
Zurück zum Zitat Bijuklic, K., et al. (2011). Midterm stability and hemodynamic performance of a transfemorally implantable nonmetallic, retrievable, and repositionable aortic valve in patients with severe aortic stenosis. Circulation: Cardiovascular Interventions, 4(6), 595–601.PubMed Bijuklic, K., et al. (2011). Midterm stability and hemodynamic performance of a transfemorally implantable nonmetallic, retrievable, and repositionable aortic valve in patients with severe aortic stenosis. Circulation: Cardiovascular Interventions, 4(6), 595–601.PubMed
26.
Zurück zum Zitat Schofer, J., et al. (2014). Prospective multicenter evaluation of the direct flow medical transcatheter aortic valve. Journal of the American College of Cardiology, 63(8), 763–768.CrossRef Schofer, J., et al. (2014). Prospective multicenter evaluation of the direct flow medical transcatheter aortic valve. Journal of the American College of Cardiology, 63(8), 763–768.CrossRef
27.
Zurück zum Zitat Jabbar, A., et al. (2016). 45 Transcatheter Aortic Valve Replacement: A Comparison of The Direct Flow Medical and Sapian 3 Aortic Valves A–Single Centre Experience. BMJ Publishing Group Ltd and British Cardiovascular Society. Jabbar, A., et al. (2016). 45 Transcatheter Aortic Valve Replacement: A Comparison of The Direct Flow Medical and Sapian 3 Aortic Valves A–Single Centre Experience. BMJ Publishing Group Ltd and British Cardiovascular Society.
28.
Zurück zum Zitat Sherif, M. A., et al. (2010). Anatomic and procedural predictors of paravalvular aortic regurgitation after implantation of the Medtronic CoreValve bioprosthesis. Journal of the American College of Cardiology, 56(20), 1623–1629.CrossRef Sherif, M. A., et al. (2010). Anatomic and procedural predictors of paravalvular aortic regurgitation after implantation of the Medtronic CoreValve bioprosthesis. Journal of the American College of Cardiology, 56(20), 1623–1629.CrossRef
29.
Zurück zum Zitat Abdel-Wahab, M., et al. (2014). Comparison of balloon-expandable vs self-expandable valves in patients undergoing transcatheter aortic valve replacement: the CHOICE randomized clinical trial. Jama, 311(15), 1503–1514.CrossRef Abdel-Wahab, M., et al. (2014). Comparison of balloon-expandable vs self-expandable valves in patients undergoing transcatheter aortic valve replacement: the CHOICE randomized clinical trial. Jama, 311(15), 1503–1514.CrossRef
30.
Zurück zum Zitat Sinning, J.-M., et al. (2012). Aortic Regurgitation Index defines severity of periprosthetic regurgitation and predicts outcome in patients after Tavi: a two-centre experience. Am Heart Assoc. Sinning, J.-M., et al. (2012). Aortic Regurgitation Index defines severity of periprosthetic regurgitation and predicts outcome in patients after Tavi: a two-centre experience. Am Heart Assoc.
Metadaten
Titel
Outcomes of Direct Flow Medical vs Sapien 3 Transcatheter Aortic Valve Devices
verfasst von
Amr S. Gamal
Subhi Akleh
Azfar Zaman
Rajiv Das
Abdelrahman Ibrahim Abushouk
Richard Edwards
Publikationsdatum
01.10.2020
Verlag
Springer US
Erschienen in
Journal of Cardiovascular Translational Research / Ausgabe 5/2020
Print ISSN: 1937-5387
Elektronische ISSN: 1937-5395
DOI
https://doi.org/10.1007/s12265-019-09948-4

Weitere Artikel der Ausgabe 5/2020

Journal of Cardiovascular Translational Research 5/2020 Zur Ausgabe

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.